The Role of hs Troponin I and NT-proBNP in Predicting Atrial Fibrillation in Patients With Permanent Pacemakers
Recruiting · NCT06174506 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Medicine and Pharmacy at Ho Chi Minh City
View the official record on ClinicalTrials.gov →What this trial is about
The goal of this clinical trial is to answer the research question whether hs Troponin I and NT-proBNP have a role in detecting atrial fibrillation in patients with pacemakers. Objectives of the study: 1. To survey some risk factors for atrial fibrillation in patients with permanent pacemakers. 2. To determine the role of hs Troponin I and NT-proBNP in predicting new-onset atrial fibrillation within follow-up time. 3. To build a model to predict the prognosis of atrial fibrillation based on the detected subclinical markers related to atrial fibrillation and classic cardiovascular risk factors.
Who can take part
Inclusion criteria
- Patient is an adult (≥ 18 years old or older)
- There is indication for permanent pacemaker placement and patient agreement to permanent pacemaker placement
- Patient agrees to participate in the study
Exclusion criteria
- Patients had a diagnosis of atrial fibrillation in their past history or atrial fibrillation is discovered at the time of participating in the study
- Severe patients, at risk of death
- Pregnant
- The patient is indicated for surgery
- Patients with eGFR ≤ 30 mL/min/1.73m2
- The patient has a serious infection
Where it is running
1 location listed.
- Cho Ray Hospital - Ho Chi Minh City, None Selected, Vietnam